Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Ascelia Pharma Major Shareholding Notification 2024

Jul 22, 2024

3132_iss_2024-07-22_a34098da-49d5-45c0-90ea-8e437d346adf.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Issuer Ascelia Pharma AB

Holder

Avanza Bank Holding AB för Försäkringsaktiebolaget Avanza Pension

Aktier
Data not given*
Data not given*

Reason for major shareholding notification Sell Date 19/07/2024 Limit for number of shares 5 %

After the transaction

Quantity
Shares 1,718,412
Directly held voting rights 0
Indirectly held voting rights 1,718,412
Percentage
Directly held shares 4.92789 %
Directly held voting rights 0 %
Indirectly held voting rights 5.07369 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 5.07369 % 1,718,412
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled
0.03498 % 11,848
Total 5.10867 % 1,730,260

Group total holdings

Voting rights 1,730,260

Percentage of voting rights 5.10867

Notes (other relevant informations according to law)

Aktierna, samt övriga instrument enligt LHF 4 kap, 2§ första stycket 1 och finansiella instrument enligt LHF 4 kap. 2§ första stycket 3 innehas av Försäkringsaktiebolaget Avanza Pension som är ett helägt dotterbolag till Avanza Bank Holding AB (publ). Det är försäkringskunder som via depåfullmakt har avyttrat de aktuella aktierna.

Published

22/07/2024 10:13

Contact

*Source of information has chosen not to submit the data

CLOSE PRINT

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25